Skip to main content
Sanofi India Ltd logo

Sanofi India Ltd — Investor Relations & Filings

Ticker · SANOFI ISIN · INE058A01010 LEI · 335800VFWLEY5V6PYH80 BSE.NS Manufacturing
Open in API
Filings indexed 1,554 across all filing types
Latest filing 2021-11-01 Regulatory Filings
Country IN India
Listing BSE.NS SANOFI

About Sanofi India Ltd

https://www.sanofi.in

Sanofi India Ltd focuses on the development, manufacturing, and marketing of a wide range of pharmaceutical products and healthcare solutions. The company operates across several therapeutic areas, including diabetes, cardiology, thrombosis, central nervous system disorders, and consumer healthcare. Its product portfolio includes established brands such as Lantus, Allegra, Combiflam, Amaryl, Avil, and Enterogermina. The organization prioritizes chronic disease management and acute care through a combination of prescription medicines and over-the-counter treatments. By integrating global research capabilities with local manufacturing excellence, the company provides specialized medical solutions aimed at improving patient health outcomes and addressing unmet medical needs.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 95% confidence The document is a short letter addressed to stock exchanges referencing Regulation 30(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It states that the Board of Directors has authorized certain officers to determine materiality of events and disclose information to stock exchanges. The document is brief (1430 characters) and does not contain any financial data, results, or detailed reports. It is an official regulatory announcement about internal authorization and compliance procedures rather than a financial report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-11-01 English
As required under regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors has authorised the Managing Director and Chief ....
Regulatory Filings Classification · 95% confidence The document is a short letter addressed to stock exchanges referencing Regulation 30(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It states that the Board of Directors has authorized certain officers to determine materiality of events and disclose information to stock exchanges. The document is brief (1430 characters) and does not contain any financial data, results, or detailed reports. It is an official regulatory announcement about internal authorization and compliance procedures rather than a financial report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-11-01 English
Loss of Share Certificates
Regulatory Filings Classification · 100% confidence The document is a formal letter addressed to stock exchanges regarding the loss of share certificates, referencing SEBI regulations. It contains no financial data, no report content, and is a notification about share certificate loss. This fits the category of Regulatory Filings (RNS) as it is a compliance-related announcement that does not fit other specific categories.
2021-10-29 English
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has received communication from its ....
Regulatory Filings Classification · 100% confidence The document is a formal letter addressed to stock exchanges regarding the loss of share certificates, referencing SEBI regulations. It contains no financial data, no report content, and is a notification about share certificate loss. This fits the category of Regulatory Filings (RNS) as it is a compliance-related announcement that does not fit other specific categories.
2021-10-29 English
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Life Insurance Corporation of India
Major Shareholding Notification Classification · 100% confidence The document is a disclosure under Regulation 29(1) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. It details the acquisition of shares by Life Insurance Corporation of India in Sanofi India Ltd., including shareholding percentages before and after acquisition, mode of acquisition, and dates. This matches the description of a Major Shareholding Notification, which involves notifying changes in significant share ownership levels crossing thresholds. The document is not an annual report, earnings release, or any other type of report but a regulatory disclosure about share acquisition.
2021-10-28 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges regarding the loss of share certificates, citing SEBI regulations. It contains details about the lost certificates and requests the information to be taken on record. The document is short (1270 characters) and does not contain financial data, management discussion, or report content. It is an official regulatory announcement related to share certificate loss, which fits best under Regulatory Filings (RNS) as it does not match other specific categories like share issue or director dealings.
2021-10-27 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.